Anika Therapeutics names Richard Hague chief commercial officer: 5 things to know

Anika Therapeutics has appointed Richard Hague as chief commercial officer.

Advertisement

Here are five things to know:

 

1. Mr. Hague has more than 30 years of commercial leadership experience in the life sciences sector.

 

2. In his new role, Mr. Hague is responsible for leading the company’s global commercial strategy.

 

3. He most recently served as vice president of sales and marketing at TEI Medical.

 

4. He has also previously served as VP of sales, marketing and commercial operations at Sanofi Biosurgery.

 

5. Anika Therapeutics is a global, integrated orthopedic medicines company focusing on developing therapeutic pain management solutions.

 

More articles on devices:
Zimmer Biomet tackles Q3 after merger; sales up 59%: 10 key notes
Miliman report analyzes procedures for lumbar spinal stenosis
ReVivo Medical receives $225k grant for spine surgery device: 5 takeaways

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.